Study Title: A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Alexander, Mariam, at alexanma@musc.edu.Study Coordinator, Shealor, Jessica, at shealorj@musc.edu.Trial opened at the following institutions: Medical University of South Carolina